Literature DB >> 15251080

Etanercept monotherapy in psoriasis.

Christopher T Ritchlin.   

Abstract

Entities:  

Year:  2004        PMID： 15251080     DOI： 10.1007/s11926-004-0040-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  4 in total

1.  Immunologic targets in psoriasis.

Authors:  Thomas S Kupper
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

2.  Immunobiologic agents for the treatment of psoriasis: clinical research delivers new hope for patients with psoriasis.

Authors:  Alice Gottlieb
Journal:  Arch Dermatol       Date:  2003-06

3.  Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.

Authors:  B J Nickoloff; T Wrone-Smith
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

Authors:  P J Mease; B S Goffe; J Metz; A VanderStoep; B Finck; D J Burge
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.